Medicare Enrolled
Dr. Sumeet Chandra, M.D.
Hematology & Oncology · Melbourne, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chandra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chandra?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chandra
Dr. Sumeet Chandra is a hematology & oncology specialist in Melbourne, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Chandra performed 259,288 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Chandra received a total of $17,164 from 87 pharmaceutical and/or device companies across 896 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chandra is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 1% volume in FL
$17,164 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 101674 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗259,288
Medicare services
Top 1% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
90,750 | $1 | $5 |
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
57,120 | $0 | $6 |
| Pembrolizumab injection (Keytruda) | 34,200 | $43 | $147 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
19,000 | $2 | $21 |
| Denosumab injection (Prolia/Xgeva) | 18,060 | $18 | $70 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
14,850 | $0 | $7 |
| Iron infusion (Monoferric) | 3,900 | $16 | $75 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
3,560 | $6 | $55 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,974 | $0 | $3 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
2,440 | $6 | $30 |
| Injection, granisetron hydrochloride, 100 mcg | 2,000 | $0 | $25 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,590 | $1 | $122 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,340 | $97 | $224 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,196 | $64 | $180 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
743 | $12 | $105 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
647 | $99 | $686 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
575 | $11 | $93 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
402 | $2 | $300 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
373 | $54 | $270 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
363 | $47 | $304 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
341 | $7 | $472 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
253 | $2 | $19 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
217 | $1 | $7 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
207 | $83 | $230 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
199 | $22 | $156 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
171 | $1 | $19 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
152 | $29 | $240 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
150 | $22 | $152 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
149 | $20 | $90 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
145 | $50 | $334 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
144 | $10 | $73 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 138 | $135 | $3,938 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
112 | $1 | $19 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
94 | $25 | $249 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
93 | $8 | $19 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
88 | $16 | $97 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
86 | $43 | $281 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
82 | $68 | $330 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
79 | $24 | $141 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
63 | $3 | $15 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
51 | $137 | $360 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
47 | $16 | $111 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
47 | $25 | $69 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
39 | $15 | $91 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
38 | $129 | $420 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
20 | $128 | $420 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
37.2% high complexity
61.4% medium
1.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$17,164
Total received (2018-2024)
Avg $2,452/year across 7 years
Top 28% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
87
Companies
896
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,020
2023
$2,074
2022
$2,860
2021
$2,971
2020
$2,308
2019
$2,364
2018
$2,566
Payments by company (2024)
PFIZER INC.
$246
Merck Sharp & Dohme LLC
$156
Janssen Biotech, Inc.
$117
Novartis Pharmaceuticals Corporation
$115
GlaxoSmithKline, LLC.
$105
Regeneron Healthcare Solutions, Inc.
$75
E.R. Squibb & Sons, L.L.C.
$74
Eisai Inc.
$71
Takeda Pharmaceuticals U.S.A., Inc.
$71
TAIHO ONCOLOGY, INC.
$70
SOBI, INC
$70
Bayer Healthcare Pharmaceuticals Inc.
$70
Incyte Corporation
$66
Astellas Pharma US Inc
$65
AstraZeneca Pharmaceuticals LP
$58
Celgene Corporation
$50
Gilead Sciences, Inc.
$50
Legend Biotech USA Inc.
$43
PUMA BIOTECHNOLOGY, INC.
$37
Genentech USA, Inc.
$35
Lilly USA, LLC
$33
Deciphera Pharmaceuticals Inc.
$29
PharmaEssentia USA Corporation
$29
Genmab U.S., Inc.
$27
Mirati Therapeutics, Inc.
$26
SERVIER PHARMACEUTICALS LLC
$25
Karyopharm Therapeutics Inc.
$25
ABBVIE INC.
$24
Stemline Therapeutics Inc.
$24
JAZZ PHARMACEUTICALS INC.
$24
BeiGene USA, Inc.
$24
Pharmacosmos Therapeutics Inc.
$23
Ipsen Biopharmaceuticals, Inc
$22
GENZYME CORPORATION
$21
Blueprint Medicines Corporation
$20
Top 3 companies account for 25.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,576
PFIZER INC.
$1,352
Janssen Biotech, Inc.
$873
E.R. Squibb & Sons, L.L.C.
$867
Amgen Inc.
$833
AstraZeneca Pharmaceuticals LP
$832
Genentech USA, Inc.
$771
Celgene Corporation
$701
Merck Sharp & Dohme Corporation
$621
Seagen Inc.
$549
Merck Sharp & Dohme LLC
$547
Incyte Corporation
$498
Daiichi Sankyo Inc.
$486
Lilly USA, LLC
$485
Astellas Pharma US Inc
$462
GENZYME CORPORATION
$439
Takeda Pharmaceuticals U.S.A., Inc.
$370
Foundation Medicine, Inc.
$303
GlaxoSmithKline, LLC.
$283
Bayer HealthCare Pharmaceuticals Inc.
$258
Regeneron Healthcare Solutions, Inc.
$235
BeiGene USA, Inc.
$212
Pharmacyclics LLC, An AbbVie Company
$189
Boehringer Ingelheim Pharmaceuticals, Inc.
$186
Eisai Inc.
$173
Kite Pharma, Inc.
$137
Karyopharm Therapeutics Inc.
$131
Ipsen Biopharmaceuticals, Inc
$130
Gilead Sciences, Inc.
$129
JAZZ PHARMACEUTICALS INC.
$119
Taiho Oncology, Inc.
$118
AngioDynamics, Inc.
$103
ARRAY BIOPHARMA INC
$101
Puma Biotechnology, Inc.
$100
TAIHO ONCOLOGY, INC.
$99
Bayer Healthcare Pharmaceuticals Inc.
$96
Pharmacosmos Therapeutics Inc.
$86
Deciphera Pharmaceuticals Inc.
$75
SOBI, INC
$70
Seattle Genetics, Inc.
$64
AMAG Pharmaceuticals, Inc.
$59
Helsinn Therapeutics (U.S.), Inc.
$58
PUMA BIOTECHNOLOGY, INC.
$56
AbbVie, Inc.
$53
Kyowa Kirin, Inc.
$50
SERVIER PHARMACEUTICALS LLC
$50
CSL Behring
$47
AbbVie Inc.
$46
ADC Therapeutics America, Inc.
$44
Pharmacyclics LLC, an AbbVie Company
$44
G1 Therapeutics, Inc.
$43
Legend Biotech USA Inc.
$43
Rigel Pharmaceuticals, Inc.
$43
Jazz Pharmaceuticals Inc.
$41
Acceleron Pharma, Inc.
$40
EISAI INC.
$39
Global Blood Therapeutics, Inc.
$38
Advanced Accelerator Applications
$36
Clovis Oncology, Inc.
$36
GE HealthCare
$34
CTI BioPharma Corp.
$33
MorphoSys, US Inc.
$31
TerSera Therapeutics LLC
$30
PharmaEssentia USA Corporation
$29
Genmab U.S., Inc.
$27
Verastem, Inc.
$27
Alnylam Pharmaceuticals Inc.
$26
Mirati Therapeutics, Inc.
$26
Secura Bio, Inc.
$25
Servier Pharmaceuticals LLC
$25
ABBVIE INC.
$24
Stemline Therapeutics Inc.
$24
TESARO, Inc.
$24
EMD Serono, Inc.
$23
Heron Therapeutics, Inc.
$21
Sun Pharmaceutical Industries Inc.
$20
TG THERAPEUTICS, INC.
$20
Innate Pharma, Inc
$20
Blueprint Medicines Corporation
$20
Sumitomo Pharma America, Inc.
$19
Alexion Pharmaceuticals, Inc.
$19
Exelixis Inc.
$18
Epizyme, Inc.,
$17
TOLMAR Pharmaceuticals, Inc.
$15
Dova Pharmaceuticals
$14
Janssen Pharmaceuticals, Inc
$14
Agios Pharmaceuticals, Inc.
$12
Top 3 companies account for 22.1% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Afstyla · Alecensa · Aliqopa · Avastin · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CALQUENCE · CHANTIX · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EVENITY · Enhertu · Epkinly · FARYDAK · FERAHEME · FOUNDATIONONE · FRUZAQLA · Farydak · GAZYVA · GILOTRIF · GIVLAARI · Gazyva · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INVOKANA · Idelvion · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LUMAKRAS · LUMOXITI · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lumoxiti · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · MYRBETRIQ · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · Padcev · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · RYBREVANT · Reblozyl · Revlimid · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAXOTERE · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · UKONIQ · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Venclexta · Vitrakvi · Vonjo · Vyloy · XALATAN · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · YONSA · ZEJULA · ZEPZELCA · Zemaira · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
12
County median income
$75,817
Nearest hospital to ZIP centroid (approximate)
ORLANDO HEALTH MELBOURNE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chandra is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chandra experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Chandra performed 90,750 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Chandra receive payments from pharmaceutical companies?
Yes. Dr. Chandra received a total of $17,164 from 87 companies across 896 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chandra's costs compare to other hematology & oncology specialists in Melbourne?
Dr. Chandra's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chandra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Melbourne
Browse hematology & oncology specialists in Melbourne ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology